Screener
aTyr Pharma ATYR Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -98.4%-13.2pp | -105.3%-25.8pp | -107.8%-28.1pp | -103.2%-25.3pp | -85.2%-23.5pp | |
| Return on invested capital | -110.8%-23.2pp | -105.9%-27.2pp | -109.2%-22.6pp | -101.5%-22.6pp | -87.5%-24.9pp | |
| Liquidity | ||||||
| Current ratio | 5.1×-0.5× | 5.8×-2.0× | 5.3×-0.2× | 5.9×+0.5× | 5.6×-2.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×-0.1× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $0.50-40.1% | $0.59-31.9% | $0.73-23.0% | $0.83-4.2% | $0.83-26.4% | |
| Valuation | ||||||
| Market capitalization | $50.14M-89.6% | $76.48M-71.5% | $76.73M-74.7% | $70.69M-44.4% | $472.61M+339% | |
| Price / book | 1.1×-5.6× | 1.3×-2.3× | 1.1×-3.2× | 0.9×-1.1× | 6.3×+5.0× |
FAQ
- Where do aTyr Pharma's ratios come from?
- Every ratio is computed from aTyr Pharma's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.